暂时性新生儿糖尿病临诊应对  

Approach to the patients with transient neonatal diabetes mellitus

作　　者：顾清[1,2] 张哲[1] 陈敏[1] 陈颖[2] 梁华[3] 李成江[1] 

机构地区：[1]浙江大学医学院附属第一医院内分泌科,杭州310003 [2]浙江大学医学院附属儿童医院保健科,杭州310003 [3]中山大学医学院附属第三医院内分泌科,广州510630

出　　处：《中华内分泌代谢杂志》2016年第6期510-513,共4页Chinese Journal of Endocrinology and Metabolism

摘　　要：暂时性新生儿糖尿病是一种少见的特殊类型糖尿病，需与1型糖尿病相鉴别，基因检测可协助进一步诊断分型，精确制定治疗方案及预测复发。磺脲类药物能改善这类患儿的胰岛素分泌，从而控制血糖。本文详细介绍1例暂时性新生儿糖尿病的诊治经过，以便临床医生重视该疾病的诊治。[Summary] Transient neonatal diabetes mellitus is a kind of rare special types of diabetes. It should be distinguished from type 1 diabetes. Genetic analysis can be used to define the subtype of neonatal diabetes mellitus, which helps us to select the most appropriate treatment and to predict the disease recurrence. Sulfonylureas is able to improve insulin secretion in most patients with transient neonatal diabetes mellitus and provide effective glycemic control. A case of transient neonatal diabetes mellitus is reported in order to call attention to the diagnosis and treatment of this disease.

关 键 词：暂时性新生儿糖尿病 基因 磺脲类药物 

分 类 号：R722.1[医药卫生—儿科]